File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1093/ehjcvp/pvv003
- WOS: WOS:000218416100008
- Find via
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Article: Patients with atrial fibrillation and diabetes: does apixaban remain the drug of choice?
Title | Patients with atrial fibrillation and diabetes: does apixaban remain the drug of choice? |
---|---|
Authors | |
Issue Date | 2015 |
Publisher | Oxford University Press. The Journal's web site is located at http://ehjcvp.oxfordjournals.org/ |
Citation | European Heart Journal - Cardiovascular Pharmacotherapy, 2015, v. 1 n. 2, p. 95-96 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/234705 |
ISSN | 2023 Impact Factor: 5.3 2023 SCImago Journal Rankings: 1.507 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hai, SHJJ | - |
dc.contributor.author | Tse, HF | - |
dc.date.accessioned | 2016-10-14T13:48:45Z | - |
dc.date.available | 2016-10-14T13:48:45Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | European Heart Journal - Cardiovascular Pharmacotherapy, 2015, v. 1 n. 2, p. 95-96 | - |
dc.identifier.issn | 2055-6837 | - |
dc.identifier.uri | http://hdl.handle.net/10722/234705 | - |
dc.language | eng | - |
dc.publisher | Oxford University Press. The Journal's web site is located at http://ehjcvp.oxfordjournals.org/ | - |
dc.relation.ispartof | European Heart Journal - Cardiovascular Pharmacotherapy | - |
dc.rights | Pre-print: Journal Title] ©: [year] [owner as specified on the article] Published by Oxford University Press [on behalf of xxxxxx]. All rights reserved. Pre-print (Once an article is published, preprint notice should be amended to): This is an electronic version of an article published in [include the complete citation information for the final version of the Article as published in the print edition of the Journal.] Post-print: This is a pre-copy-editing, author-produced PDF of an article accepted for publication in [insert journal title] following peer review. The definitive publisher-authenticated version [insert complete citation information here] is available online at: xxxxxxx [insert URL that the author will receive upon publication here]. | - |
dc.title | Patients with atrial fibrillation and diabetes: does apixaban remain the drug of choice? | - |
dc.type | Article | - |
dc.identifier.email | Hai, SHJJ: haishjj@hku.hk | - |
dc.identifier.email | Tse, HF: hftse@hkucc.hku.hk | - |
dc.identifier.authority | Hai, SHJJ=rp02047 | - |
dc.identifier.authority | Tse, HF=rp00428 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1093/ehjcvp/pvv003 | - |
dc.identifier.hkuros | 269562 | - |
dc.identifier.volume | 1 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 95 | - |
dc.identifier.epage | 96 | - |
dc.identifier.isi | WOS:000218416100008 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 2055-6837 | - |